mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0005 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0008 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0008 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0009 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |